Skip to main content
Skip to section navigation
Skip to footer
Home
About
Overview
Management Team
Board of Directors
Advisory Board
Pipeline
Overview
XRx-008 for Autosomal Dominant Polycystic Kidney Disease
XRx-101 for Coronavirus/COVID-19
XRX-225 for Type 2 Diabetic Nephropathy
Publications
Technology
News & Media
Press Releases
Events
In the News
Investors
Overview
News & Events
Presentations
Company Info
Financial Info
Stock Data
SEC Filings
SEDAR+
Governance
Contact
Publications
Pipeline
Pipeline
Overview
XRx-008 for Autosomal Dominant Polycystic Kidney Disease
XRx-101 for Coronavirus/COVID-19
XRX-225 for Type 2 Diabetic Nephropathy
Publications
The Case for Uric Acid-lowering Treatment in Patients with Hyperuricaemia and CKD
July 11, 2019
View Article
Extrapulmonary Manifestations of COVID-19
July 10, 2020
View Article
Platelet and Red Blood Cell Counts, as well as the Concentrations of Uric Acid, but Not Homocysteinaemia or Oxidative Stress, Contribute Mostly to Platelet Reactivity in Older Adults
Jan. 16, 2019
View Article
Hematologic Findings and Complications of COVID-19
Apr. 13, 2020
View Article
Endothelial Cell Infection and Endotheliitis in COVID-19
Apr. 17, 2020
View Article